Nicolas G. Bazan MD, PhD

Nicolas G. Bazan, M.D., Ph.D., has been called “a true renaissance man”: research scientist, teacher, mentor, community leader, author, screenplay co-writer/executive movie producer, patron of the arts, and entrepreneur. Born in Argentina, M.D. at the University of Tucuman in Argentina, trained at Columbia University P&S, NYC, and Harvard Med. School. He was appointed faculty at age 26 at Clarke Institute of Psychiatry/University of Toronto.

Founding Director of the Neuroscience Center of Excellence, School of Medicine, LSU Health New Orleans, inaugural founder of The Ernest C. and Yvette C. Villere Chair for Research in Retinal Degeneration (1984-), and appointed to the highest academic rank in the LSU System, a Boyd Professor (1994-). He is also a Foreign Adjunct Professor of Neuroscience, at Karolinska Institutet, Stockholm, Sweden.

His research is focused on understanding cellular/molecular mechanisms to prevent and cure Alzheimer’s disease, other neurodegenerative diseases, and other neurological conditions, and is reflected in >500 peer-reviewed publications (PubMed), in addition to monographs, books, and chapters, an h-index of 103 (Google Scholar), an i10-index of 447, and greater than 44,273 citations to his work (Google Scholar) as of March 24, 2022. He is also the inventor of >130 patents/provisional patents.

Currently, he is applying his discoveries as patents licensed from LSU in startup companies that he co-founded. They are NeuResto Therapeutics, LLC (Alzheimer’s, Parkinson’s, retinal degenerations, stroke, traumatic brain injury, and other brain and retina diseases; neuresto.com); South Rampart Pharma, LLC (non-addictive, non-toxic painkiller; southrampartpharma.com) and CurVirBiotech, LLC (preventive and therapeutics against viral infections, particularly SARS-CoV-2 that causes COVID-19; curvirbiotech.com).